IRINOTECAN WITH BIWEEKLY, LOW DOSE LEUCOVORIN AND BOLUS AND CONTINUOUS INFUSION 5-FLUOROURACIL (MODIFIED FOLFIRI) AS FIRST LINE THERAPY FOR PATIENTS WITH RECURRENT OR METASTATIC GASTRIC CANCER

被引：0
|
作者：
Oh, S. Y. [1 ]
Kim, B. G. [1 ]
Kwon, H. [1 ]
Lee, S. [1 ]
Lee, D. M. [1 ]
Jang, J. S. [1 ]
Kim, M. C. [1 ]
Kim, S. [1 ]
Kim, H. [1 ]
机构：
[1] Dong A Univ, Coll Med, Pusan, South Korea
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：183 / 183
页数：1
相关论文
共 50 条
  • [21] Randomized study of weekly irinotecan plus high-dose 5-fluorouracil (FUIRI) versus biweekly irinotecan plus 5-fluorouracil/leucovorin (FOLFIRI) as first-line chemotherapy for patients with metastatic colorectal cancer: a Spanish Cooperative Group for the Treatment of Digestive Tumors Study
    Aranda, E.
    Valladares, M.
    Martinez-Villacampa, M.
    Benavides, M.
    Gomez, A.
    Massutti, B.
    Marcuello, E.
    Constenla, M.
    Camara, J. C.
    Carrato, A.
    Duenas, R.
    Reboredo, M.
    Navarro, M.
    Diaz-Rubio, E.
    ANNALS OF ONCOLOGY, 2009, 20 (02) : 251 - 257
  • [22] A Phase II Study of Irinotecan, Continuous 5-Fluorouracil, and Leucovorin (FOLFIRI) Combination Chemotherapy for Patients With Recurrent or Metastatic Gastric Cancer Previously Treated With a Fluoropyrimidine-Based Regimen
    Kim, Seok Hyun
    Lee, Gyeong-Won
    Go, Se Il
    Cho, Su Hee
    Kim, Hyun Jin
    Kim, Hun Gu
    Kang, Jung Hun
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (06): : 572 - 576
  • [23] A phase II study of oxaliplatin with low-dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) for gastric cancer patients with malignant ascites
    Oh, Sung Yong
    Kwon, Hyuk-Chan
    Lee, Suee
    Lee, Dong Mee
    Yoo, Hyun Seung
    Kim, Sung-Hyun
    Jang, Jin Seok
    Kim, Min Chan
    Jeong, Jin-Sook
    Kim, Hyo-Jin
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 37 (12) : 930 - 935
  • [24] Panitumumab with irinotecan/leucovorin/5-fluorouracil for first-line treatment of metastatic colorectal cancer
    Berlin, Jordan
    Posey, James
    Tchekmedyian, Simon
    Hu, Eddie
    Chan, David
    Malik, Imtiaz
    Yang, Liqiang
    Amado, Rafael G.
    Hecht, J. Randolph
    CLINICAL COLORECTAL CANCER, 2007, 6 (06) : 427 - 432
  • [25] Oxaliplatin Combined with Continuous Infusion of 5-Fluorouracil as First-Line Chemotherapy in Patients with Metastatic or Recurrent Gastric Adenocarcinoma
    Lim, Jae Yun
    Cho, Jae Yong
    Oh, Kyung Jin
    Choi, Seung Ho
    Lee, Sang In
    Jeung, Hei-Cheul
    CHEMOTHERAPY, 2009, 55 (04) : 200 - 206
  • [26] First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer
    Claus-Henning Köhne
    Ralf Hofheinz
    Laurent Mineur
    Henry Letocha
    Richard Greil
    Josef Thaler
    Eva Fernebro
    Erick Gamelin
    Lucy DeCosta
    Meinolf Karthaus
    Journal of Cancer Research and Clinical Oncology, 2012, 138 : 65 - 72
  • [27] First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer
    Koehne, Claus-Henning
    Hofheinz, Ralf
    Mineur, Laurent
    Letocha, Henry
    Greil, Richard
    Thaler, Josef
    Fernebro, Eva
    Gamelin, Erick
    DeCosta, Lucy
    Karthaus, Meinolf
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (01) : 65 - 72
  • [28] Phase 2 Study of Modified Irinotecan and Bolus 5-Fluorouracil/l-Leucovorin in Japanese Metastatic Colorectal Cancer Patients
    Baba, Eishi
    Fujishima, Hiromitsu
    Makiyama, Akitaka
    Uchino, Keita
    Tanaka, Risa
    Esaki, Taito
    Kusaba, Hitoshi
    Mitsugi, Kenji
    Nakano, Shuji
    Akashi, Koichi
    ADVANCES IN THERAPY, 2012, 29 (03) : 287 - 296
  • [29] Phase 2 Study of Modified Irinotecan and Bolus 5-Fluorouracil/l-Leucovorin in Japanese Metastatic Colorectal Cancer Patients
    Eishi Baba
    Hiromitsu Fujishima
    Akitaka Makiyama
    Keita Uchino
    Risa Tanaka
    Taito Esaki
    Hitoshi Kusaba
    Kenji Mitsugi
    Shuji Nakano
    Koichi Akashi
    Advances in Therapy, 2012, 29 : 287 - 296
  • [30] Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer
    Andreas Teufel
    Silke Steinmann
    Jürgen Siebler
    Christiane Zanke
    Herbert Hohl
    Bernd Adami
    M Schroeder
    O Klein
    Thomas Höhler
    Peter R Galle
    Michael Heike
    Markus Moehler
    BMC Cancer, 4
12345